Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating) saw a large decline in short interest in the month of July. As of July 15th, there was short interest totalling 12,000 shares, a decline of 15.5% from the June 30th total of 14,200 shares. Approximately 0.4% of the shares of the company are short sold. Based on an average trading volume of 5,900 shares, the days-to-cover ratio is currently 2.0 days.
Institutional Trading of Pro-Dex
A number of hedge funds and other institutional investors have recently modified their holdings of PDEX. State Street Corp raised its position in shares of Pro-Dex by 5.8% during the first quarter. State Street Corp now owns 11,923 shares of the medical instruments supplier’s stock worth $197,000 after purchasing an additional 650 shares during the period. LSV Asset Management raised its position in shares of Pro-Dex by 13.9% during the first quarter. LSV Asset Management now owns 35,581 shares of the medical instruments supplier’s stock worth $588,000 after purchasing an additional 4,346 shares during the period. Finally, JPMorgan Chase & Co. raised its position in shares of Pro-Dex by 59.2% during the first quarter. JPMorgan Chase & Co. now owns 20,863 shares of the medical instruments supplier’s stock worth $345,000 after purchasing an additional 7,762 shares during the period. Institutional investors own 16.73% of the company’s stock.
Pro-Dex Stock Down 0.3 %
PDEX opened at $15.75 on Friday. Pro-Dex has a one year low of $12.40 and a one year high of $32.00. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.10 and a current ratio of 3.64. The stock’s fifty day moving average is $15.76 and its 200-day moving average is $17.01. The company has a market capitalization of $57.00 million, a PE ratio of 18.10 and a beta of 1.01.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on PDEX shares. Ascendiant Capital Markets reduced their price target on Pro-Dex to $30.00 and set a “na” rating for the company in a research report on Monday, May 16th. StockNews.com began coverage on Pro-Dex in a research report on Monday. They set a “hold” rating for the company.
Pro-Dex, Inc designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- How Does Freeport McMoran Inc Compare to Its Sector Competitors?
- 3 Hotel Stocks to Consider Checking into After Earnings
- Can FuelCell Energy Surge Higher This Year?
- Is It Time to Take a Ride on Cedar Fair Stock?
- Time To Take A Serious Look At Nikola Stock As Production Starts
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.